Evidence map›Paper›PMID 31838858›Full record

ArticleAIDS research and human retroviruses2020

Timing of Antiretroviral Therapy Initiation Determines Rectal Natural Killer Cell Populations.

Netanya S Utay, Karen J Vigil, Anoma Somasunderam, Paula C Aulicino, Beverly Smulevitz, Simbo Chiadika, David S Wolf, Jason T Kimata, Roberto C Arduino

Open access · greenAbstract read
In one paragraph

Article in AIDS research and human retroviruses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. CD8Cell reports. Medicine · 2026
    Review
  2. Gut Innate Immunity and HIV Pathogenesis.Current HIV/AIDS reports · 2021
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Netanya S UtayDivision of General Medicine, Department of Internal Medicine, McGovern Medical School, UT Health Science Center at Houston, Houston, Texas.
Karen J VigilDivision of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, UT Health Science Center at Houston, Houston, Texas.
Anoma SomasunderamDivision of General Medicine, Department of Internal Medicine, McGovern Medical School, UT Health Science Center at Houston, Houston, Texas.
Paula C AulicinoLaboratorio de Biología Celular y Retrovirus, Hospital de Pediatría "Juan P. Garrahan"-CONICET, Buenos Aires, Argentina.
Beverly SmulevitzDivision of Cardiology, Department of Internal Medicine, McGovern Medical School, UT Health Science Center at Houston, Houston, Texas.
Simbo ChiadikaDivision of Cardiology, Department of Internal Medicine, McGovern Medical School, UT Health Science Center at Houston, Houston, Texas.
David S WolfThe Medical Clinic of Houston, LLP, Houston, Texas.
Jason T KimataDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
Roberto C ArduinoDivision of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, UT Health Science Center at Houston, Houston, Texas.
Baylor College of Medicine · USConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BUTEL, JANET S · 1994 to 2015
$21.7M
Bifunctional Chimeric Antigen Receptors for clearing HIVR33AI116167 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI KIMATA, JASON T. · 2018 to 2020
$1.5M
Bifunctional Chimeric Antigen Receptors for clearing HIVR21AI116167 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI KIMATA, JASON T. · 2016 to 2017
$472k
NCI NIH HHS P30 CA125123NIAID NIH HHS R21 AI116167NIAID NIH HHS R33 AI116167
6 · The paper itself

Abstract

Despite antiretroviral therapy (ART), innate and adaptive immunologic damage persists in the periphery and gut. T memory stem cells (Tscm) and natural killer (NK) cells are pivotal for host defense. Tscm are memory cells capable of antigen response and self-renewal, and circulating and gut NK cell populations may facilitate HIV control. The impact of early ART on circulating and gut Tscm and NK cells is unknown. We enrolled participants who initiated ART during acute versus chronic HIV-1 infection versus no ART in chronic infection. We performed flow cytometry to identify NK and Tscm cells in the blood and rectum and polymerase chain reaction to quantify the HIV-1 reservoir in both sites. We used the Mann-Whitney

Indexed as

Acute DiseaseAdultAnti-Retroviral AgentsCarotid Artery DiseasesCD4 Lymphocyte CountHeart Disease Risk FactorsHIV-1HIV InfectionsHumansKiller Cells, NaturalMiddle AgedRectumStem CellsT-LymphocytesYoung AdultAnti-Retroviral Agentsacute HIVgutHIVNK cellsTscm

Identifiers

PMID31838858
PMCPMC7185341
OpenAlexW2996159019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.